FDA Inspection 1193493 - GlaxoSmithKline Biologicals - November 08, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns GlaxoSmithKline Biologicals, with an inspection on November 8, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: GlaxoSmithKline Biologicals
Inspection Date: November 8, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · e865d539-7363-43f7-b06a-9bb6bef4b8da